$33.6 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 24 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 46.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VEA | Sell | VANGUARD FTSE DEV MKTSetfs | $3,413,000 | -4.6% | 82,592 | -9.3% | 10.15% | +8.5% |
| VOO | Sell | VANGUARD 500 INDEX FUNDetfs | $3,041,000 | -7.3% | 13,695 | -9.7% | 9.04% | +5.5% |
| VOE | Sell | VANGUARD MID-CAP VALUE ETFetfs | $3,001,000 | -8.9% | 29,172 | -9.7% | 8.92% | +3.7% |
| VWO | Sell | VANGUARD MSCI EMERGING MKTSetfs | $2,627,000 | -6.8% | 64,329 | -9.4% | 7.81% | +6.1% |
| APEN | Sell | APOLLO ENDOSURGERY INC | $1,217,000 | -43.7% | 154,301 | -10.5% | 3.62% | -35.9% |
| VDE | Sell | VANGUARD ENERGY ETFetfs | $908,000 | -17.0% | 10,260 | -9.3% | 2.70% | -5.5% |
| VNQ | Sell | VANGUARD REIT ETFetfs | $765,000 | -5.8% | 9,189 | -6.5% | 2.27% | +7.2% |
| KO | Exit | COCA-COLA CO | $0 | – | -25 | -100.0% | -0.00% | – |
| HAL | Exit | HALLIBURTON CO | $0 | – | -30 | -100.0% | -0.00% | – |
| NVDA | Exit | NVIDIA CORP | $0 | – | -100 | -100.0% | -0.03% | – |
| SU | Exit | SUNCOR ENERGY INC | $0 | – | -1,500 | -100.0% | -0.12% | – |
| HD | Exit | HOME DEPOT INC | $0 | – | -900 | -100.0% | -0.34% | – |
| FISV | Exit | FISERV INC | $0 | – | -1,600 | -100.0% | -0.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
| 3 | 2023-06-02 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.